Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Feb 10;36(5):435-437.
doi: 10.1200/JCO.2017.76.5495. Epub 2017 Dec 14.

STOMPing Out Hormone-Sensitive Metastases With Local Therapies in Prostate Cancer

Ryan M Phillips  1 , Jonathan Hayman  1 , Phuoc T Tran  1
Affiliations
Editorial

STOMPing Out Hormone-Sensitive Metastases With Local Therapies in Prostate Cancer

Ryan M Phillips et al. J Clin Oncol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST

Disclosures provided by the authors are available with this article at jco.org.

AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST

STOMPing Out Hormone-Sensitive Metastases With Local Therapies in Prostate Cancer

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO’s conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/site/ifc.

Comment in

Comment on

References

    1. American Cancer Society: Cancer Facts & Figures 2017. Atlanta, GA, American Cancer Society, 2017.
    1. Nguyen PL, Alibhai SM, Basaria S, et al.: Adverse effects of androgen deprivation therapy and strategies to mitigate them. Eur Urol 67:825–836, 2015 - PubMed
    1. Virgo KS, Basch E, Loblaw DA, et al.: Second-line hormonal therapy for men with chemotherapy-naïve, castration-resistant prostate cancer: American Society of Clinical Oncology provisional clinical opinion. J Clin Oncol 35:1952–1964, 2017 - PubMed
    1. Hellman S, Weichselbaum RR: Oligometastases. J Clin Oncol 13:8–10, 1995 - PubMed
    1. Tran PT, Antonarakis ES: Altering the natural history of oligometastatic prostate cancer with local therapies: Reality versus illusion. J Oncol Pract 13:21–24, 2017 - PMC - PubMed